U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
This is a summary aggregated from NPR News. Read the complete article on the original site:
Read full article at NPR News
